Published in Arch Dermatol on March 01, 2010
Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med (2012) 6.90
Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer. JAMA Intern Med (2013) 4.59
Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol (2014) 3.04
Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst (2010) 2.80
Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol (2012) 2.49
Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis. BMJ (2012) 2.43
International prevalence of indoor tanning: a systematic review and meta-analysis. JAMA Dermatol (2014) 2.38
Nonmelanoma skin cancer in inflammatory bowel disease: a review. Inflamm Bowel Dis (2010) 2.36
Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet (2010) 2.14
Smoothened variants explain the majority of drug resistance in basal cell carcinoma. Cancer Cell (2015) 2.03
From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest (2012) 2.01
Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology (2012) 1.97
Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma. J Clin Oncol (2013) 1.83
Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations. Curr Dermatol Rep (2014) 1.79
Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011. Am J Prev Med (2014) 1.55
Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER). Lancet (2013) 1.50
ZNF750 is a p63 target gene that induces KLF4 to drive terminal epidermal differentiation. Dev Cell (2012) 1.47
In vivo reflectance confocal microscopy of shave biopsy wounds: feasibility of intraoperative mapping of cancer margins. Br J Dermatol (2010) 1.39
UV radiation and the skin. Int J Mol Sci (2013) 1.37
Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med (2015) 1.33
Indoor tanning and risk of early-onset basal cell carcinoma. J Am Acad Dermatol (2011) 1.26
Basal-cell carcinoma incidence and associated risk factors in U.S. women and men. Am J Epidemiol (2013) 1.25
Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomes. J Contemp Brachytherapy (2014) 1.24
Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol Biomarkers Prev (2010) 1.24
Recent advances in the prevention and treatment of skin cancer using photodynamic therapy. Expert Rev Anticancer Ther (2010) 1.21
Host phenotype characteristics and MC1R in relation to early-onset basal cell carcinoma. J Invest Dermatol (2011) 1.19
Roles of the immune system in skin cancer. Br J Dermatol (2011) 1.12
Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting. Dermatol Surg (2011) 1.10
Cutaneous squamous cell carcinoma of the head and neck. J Skin Cancer (2011) 1.09
Obesity and the incidence of skin cancer in US Caucasians. Cancer Causes Control (2012) 1.08
Risk of a second primary cancer after non-melanoma skin cancer in white men and women: a prospective cohort study. PLoS Med (2013) 1.06
Long-term ultraviolet flux, other potential risk factors, and skin cancer risk: a cohort study. Cancer Epidemiol Biomarkers Prev (2014) 1.05
Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis. J Am Acad Dermatol (2014) 1.03
Hat, shade, long sleeves, or sunscreen? Rethinking US sun protection messages based on their relative effectiveness. Cancer Causes Control (2011) 1.03
Nanoelectroablation therapy for murine basal cell carcinoma. Biochem Biophys Res Commun (2012) 1.03
Indoor tanning among high school students in the United States, 2009 and 2011. JAMA Dermatol (2014) 1.02
HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst (2013) 1.02
Psychosocial correlates of sun protection behaviors among U.S. Hispanic adults. J Behav Med (2014) 1.01
A population-based study of DNA repair gene variants in relation to non-melanoma skin cancer as a marker of a cancer-prone phenotype. Carcinogenesis (2012) 1.01
Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol (2013) 1.00
Confocal microscopy to guide erbium:yttrium aluminum garnet laser ablation of basal cell carcinoma: an ex vivo feasibility study. J Biomed Opt (2013) 0.99
A population-based case-control study of urinary arsenic species and squamous cell carcinoma in New Hampshire, USA. Environ Health Perspect (2013) 0.99
Serpin peptidase inhibitor clade A member 1 (SerpinA1) is a novel biomarker for progression of cutaneous squamous cell carcinoma. Am J Pathol (2011) 0.97
Practices of unregulated tanning facilities in Missouri: implications for statewide legislation. Pediatrics (2013) 0.96
Genomic analysis of metastatic cutaneous squamous cell carcinoma. Clin Cancer Res (2015) 0.96
Correlates of intentional tanning among adolescents in the United States: a systematic review of the literature. J Adolesc Health (2013) 0.96
Is a personal history of nonmelanoma skin cancer associated with increased or decreased risk of other cancers? Cancer Epidemiol Biomarkers Prev (2014) 0.95
Reversing the aging stromal phenotype prevents carcinoma initiation. Aging (Albany NY) (2011) 0.95
Loss of hairless confers susceptibility to UVB-induced tumorigenesis via disruption of NF-kappaB signaling. PLoS One (2012) 0.94
Three-dimensional imaging of normal skin and nonmelanoma skin cancer with cellular resolution using Gabor domain optical coherence microscopy. J Biomed Opt (2012) 0.94
Clinical study of noninvasive in vivo melanoma and nonmelanoma skin cancers using multimodal spectral diagnosis. J Biomed Opt (2014) 0.94
Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes. Cell Death Dis (2015) 0.93
Melanoma treatment costs: a systematic review of the literature, 1990-2011. Am J Prev Med (2012) 0.93
Preventative topical diclofenac treatment differentially decreases tumor burden in male and female Skh-1 mice in a model of UVB-induced cutaneous squamous cell carcinoma. Carcinogenesis (2012) 0.93
Alcohol consumption and risk of melanoma and non-melanoma skin cancer in the Women's Health Initiative. Cancer Causes Control (2013) 0.92
Nitric oxide-producing myeloid-derived suppressor cells inhibit vascular E-selectin expression in human squamous cell carcinomas. J Invest Dermatol (2012) 0.92
The initial experience of electronic brachytherapy for the treatment of non-melanoma skin cancer. Radiat Oncol (2010) 0.91
Total body skin examination for skin cancer screening among U.S. adults from 2000 to 2010. Prev Med (2014) 0.90
Toll-like receptors and skin cancer. Front Immunol (2014) 0.90
Sestrin2 protein positively regulates AKT enzyme signaling and survival in human squamous cell carcinoma and melanoma cells. J Biol Chem (2014) 0.90
Fisetin inhibits UVB-induced cutaneous inflammation and activation of PI3K/AKT/NFκB signaling pathways in SKH-1 hairless mice. Photochem Photobiol (2014) 0.90
Ultraviolet radiation-induced non-melanoma skin cancer: Regulation of DNA damage repair and inflammation. Genes Dis (2014) 0.90
Strategies to reduce indoor tanning: current research gaps and future opportunities for prevention. Am J Prev Med (2013) 0.89
Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma. J Invest Dermatol (2013) 0.89
Effects of magnolol on UVB-induced skin cancer development in mice and its possible mechanism of action. BMC Cancer (2011) 0.89
Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials. J Natl Cancer Inst (2011) 0.88
The grape antioxidant resveratrol for skin disorders: promise, prospects, and challenges. Arch Biochem Biophys (2011) 0.88
Estimating the economic costs of skin cancer in New South Wales, Australia. BMC Public Health (2015) 0.88
Automated identification of basal cell carcinoma by polarization-sensitive optical coherence tomography. Biomed Opt Express (2014) 0.88
Framing Indoor Tanning Warning Messages to Reduce Skin Cancer Risks Among Young Women: Implications for Research and Policy. Am J Public Health (2015) 0.87
Combination of oral vitamin D3 with photodynamic therapy enhances tumor cell death in a murine model of cutaneous squamous cell carcinoma. Photochem Photobiol (2014) 0.87
Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer. Int J Oncol (2012) 0.87
Surgical removal of the parametrial fat pads stimulates apoptosis and inhibits UVB-induced carcinogenesis in mice fed a high-fat diet. Proc Natl Acad Sci U S A (2012) 0.87
A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important. Pigment Cell Melanoma Res (2012) 0.87
CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma. Cancer Discov (2015) 0.86
ETS family transcriptional regulators drive chromatin dynamics and malignancy in squamous cell carcinomas. Elife (2015) 0.86
Cyclooxygenases: mediators of UV-induced skin cancer and potential targets for prevention. J Invest Dermatol (2014) 0.86
The epidemic of nonmelanoma skin cancer and the widespread use of statins: Is there a connection? Dermatoendocrinol (2010) 0.86
Caffeine decreases phospho-Chk1 (Ser317) and increases mitotic cells with cyclin B1 and caspase 3 in tumors from UVB-treated mice. Cancer Prev Res (Phila) (2011) 0.86
Gain-framed messages do not motivate sun protection: a meta-analytic review of randomized trials comparing gain-framed and loss-framed appeals for promoting skin cancer prevention. Int J Environ Res Public Health (2012) 0.86
Mechanisms of Caffeine-Induced Inhibition of UVB Carcinogenesis. Front Oncol (2013) 0.86
Preventing skin cancer through reduction of indoor tanning: current evidence. Am J Prev Med (2013) 0.86
Squamous cell carcinoma of the skin: Emerging need for novel biomarkers. World J Clin Oncol (2013) 0.85
Shining light on skin pigmentation: the darker and the brighter side of effects of UV radiation. Photochem Photobiol (2012) 0.85
Advanced basal cell carcinoma, the hedgehog pathway, and treatment options - role of smoothened inhibitors. Biologics (2015) 0.85
Ingenol mebutate gel (picato): a novel agent for the treatment of actinic keratoses. P T (2014) 0.85
Differential effects of topical vitamin E and C E Ferulic® treatments on ultraviolet light B-induced cutaneous tumor development in Skh-1 mice. PLoS One (2013) 0.85
Vitamin D and skin cancer. Photochem Photobiol (2014) 0.85
Automatic dirt trail analysis in dermoscopy images. Skin Res Technol (2012) 0.85
Terminal epidermal differentiation is regulated by the interaction of Fra-2/AP-1 with Ezh2 and ERK1/2. Genes Dev (2014) 0.85
A pilot study of ultrasound-guided electronic brachytherapy for skin cancer. J Contemp Brachytherapy (2015) 0.85
Survival after squamous cell and basal cell carcinoma of the skin: A retrospective cohort analysis. Int J Cancer (2015) 0.85
Analysis of skin lesions using laminar optical tomography. Biomed Opt Express (2012) 0.85
Focal adhesion complex proteins in epidermis and squamous cell carcinoma. Cell Cycle (2013) 0.84
Fractionated laser resurfacing corrects the inappropriate UVB response in geriatric skin. J Invest Dermatol (2012) 0.84
Skin Carcinogenesis Studies Using Mouse Models with Altered Polyamines. Cancer Growth Metastasis (2015) 0.84
Cyanidin-3-glucoside inhibits UVB-induced oxidative damage and inflammation by regulating MAP kinase and NF-κB signaling pathways in SKH-1 hairless mice skin. Toxicol Appl Pharmacol (2014) 0.84
A phase III skin cancer chemoprevention study of DFMO: long-term follow-up of skin cancer events and toxicity. Cancer Prev Res (Phila) (2012) 0.84
Computer-aided diagnosis of skin lesions using conventional digital photography: a reliability and feasibility study. PLoS One (2013) 0.84
MC1R gene variants and non-melanoma skin cancer: a pooled-analysis from the M-SKIP project. Br J Cancer (2015) 0.84
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Indoor tanning and risk of melanoma: a case-control study in a highly exposed population. Cancer Epidemiol Biomarkers Prev (2010) 3.95
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol (2008) 3.95
AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. J Am Acad Dermatol (2012) 3.49
Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc (2004) 3.40
The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol (2006) 3.30
Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol (2003) 3.22
Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol (2005) 3.04
Adherence, the fourth dimension in the geometry of dermatological treatment. Arch Dermatol (2009) 2.91
Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol (2007) 2.81
In the United States, blacks and Asian/Pacific Islanders are more likely than whites to seek medical care for atopic dermatitis. Arch Dermatol (2002) 2.75
Addition of dermoscopy to conventional naked-eye examination in melanoma screening: a randomized study. J Am Acad Dermatol (2004) 2.54
The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol (2005) 2.26
A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption. J Am Acad Dermatol (2009) 2.20
A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis. J Am Acad Dermatol (2004) 2.05
Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial. J Invest Dermatol (2012) 2.04
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol (2011) 2.03
Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening. Cancer (2012) 2.02
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol (2008) 1.99
Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002. J Am Acad Dermatol (2006) 1.98
Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol (2004) 1.94
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol (2009) 1.94
A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol (2003) 1.92
Development and reliability of a brief skin cancer risk assessment tool. Cancer Detect Prev (2003) 1.90
Prevalence and correlates of skin cancer screening among middle-aged and older white adults in the United States. Am J Med (2010) 1.90
Trends in nonmelanoma skin cancer mortality rates in the United States, 1969 through 2000. J Invest Dermatol (2007) 1.82
Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol (2006) 1.76
Interleukin-12, interleukin-23, and psoriasis: current prospects. J Am Acad Dermatol (2007) 1.76
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol (2009) 1.76
Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst (2002) 1.70
The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol (2005) 1.68
Sunlight, tanning booths, and vitamin D. J Am Acad Dermatol (2005) 1.68
Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Cancer (2009) 1.65
Adherence in dermatology: a review of the last 20 years. J Dermatolog Treat (2006) 1.64
Melanoma thickness trends in the United States, 1988-2006. J Invest Dermatol (2009) 1.60
A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis. J Am Acad Dermatol (2006) 1.59
Factors influencing vitamin D status. Acta Derm Venereol (2011) 1.56
Drug samples in dermatology: special considerations and recommendations for the future. J Am Acad Dermatol (2010) 1.55
Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol (2010) 1.53
Written action plans: potential for improving outcomes in children with atopic dermatitis. J Am Acad Dermatol (2008) 1.52
Eligibility creep: a cause for placebo group improvement in controlled trials of psoriasis treatments. J Am Acad Dermatol (2007) 1.51
Inflammation in rosacea and acne: Implications for patient care. J Drugs Dermatol (2011) 1.51
A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. Arch Dermatol (2010) 1.50
Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period. J Am Acad Dermatol (2007) 1.50
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol (2009) 1.48
UV light abuse as a substance-related disorder: clinical implications. Arch Dermatol (2008) 1.48
Determining the safety of office-based surgery: what 10 years of Florida data and 6 years of Alabama data reveal. Dermatol Surg (2011) 1.48
Mohs micrographic surgery utilization in the Medicare population, 2009. Dermatol Surg (2012) 1.47
Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol (2004) 1.45
Members of the national psoriasis foundation: more extensive disease and better informed about treatment options. Arch Dermatol (2005) 1.45
Trends in pediatric psoriasis outpatient health care delivery in the United States. Arch Dermatol (2011) 1.44
Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol (2006) 1.44
Treatment of psoriasis in children: is there a role for antibiotic therapy and tonsillectomy? Pediatr Dermatol (2003) 1.43
Hyperpigmentation: an overview of the common afflictions. Dermatol Nurs (2004) 1.43
Dermatosis neglecta: a series of case reports and review of other dirty-appearing dermatoses. Dermatol Online J (2006) 1.42
Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life. J Am Acad Dermatol (2005) 1.42
Trends in Mohs surgery from 1995 to 2010: an analysis of nationally representative data. Dermatol Surg (2015) 1.42
Scientific and regulatory issues related to indoor tanning. J Am Acad Dermatol (2004) 1.42
Adolescents' use of indoor tanning: a large-scale evaluation of psychosocial, environmental, and policy-level correlates. Am J Public Health (2011) 1.41
Induction of withdrawal-like symptoms in a small randomized, controlled trial of opioid blockade in frequent tanners. J Am Acad Dermatol (2006) 1.40
Concordance of frozen and permanent sections for the diagnosis of skin lesions. Dermatol Surg (2010) 1.40
How much of a topical agent should be prescribed for children of different sizes? J Dermatolog Treat (2006) 1.40
Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents. J Am Acad Dermatol (2006) 1.40
Where did current academic dermatologists train? J Am Acad Dermatol (2010) 1.39
Increase in procedures performed at dermatology office visits from 1995 to 2001. Dermatol Surg (2005) 1.39
Phototherapy trends in dermatology. J Dermatolog Treat (2013) 1.38
Use of indoor tanning sunlamps by US youth, ages 11-18 years, and by their parent or guardian caregivers: prevalence and correlates. Pediatrics (2002) 1.38
Costs of Keratinocyte Carcinoma (Nonmelanoma Skin Cancer) and Actinic Keratosis Treatment in the Veterans Health Administration. Dermatol Surg (2016) 1.37
Ultraviolet exposure is a reinforcing stimulus in frequent indoor tanners. J Am Acad Dermatol (2004) 1.35
Association of UV index, latitude, and melanoma incidence in nonwhite populations--US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001. Arch Dermatol (2005) 1.35
Use of electronic medical records differs by specialty and office settings. J Am Med Inform Assoc (2013) 1.34
Poor adherence to treatments: a fundamental principle of dermatology. Arch Dermatol (2007) 1.34
Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial. J Am Acad Dermatol (2005) 1.34
Promoting sun safety among US Postal Service letter carriers: impact of a 2-year intervention. Am J Public Health (2007) 1.33
Youth access to artificial UV radiation exposure: practices of 3647 US indoor tanning facilities. Arch Dermatol (2009) 1.32
Quality of life in patients with psoriasis. Health Qual Life Outcomes (2006) 1.31
Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference. Cutis (2002) 1.27
Palisaded neutrophilic granulomatous dermatitis in rheumatoid arthritis. J Am Acad Dermatol (2002) 1.26
The safety of liposuction: results of a national survey. Dermatol Surg (2002) 1.25
Pharmacoeconomic considerations in treating actinic keratosis. Pharmacoeconomics (2009) 1.24
Optimizing topical therapies for treating psoriasis: a consensus conference. Cutis (2010) 1.22
Study of Nevi in Children (SONIC): baseline findings and predictors of nevus count. Am J Epidemiol (2008) 1.21
The economic impact of non-melanoma skin cancer: a review. J Natl Compr Canc Netw (2010) 1.20
The effect of reminder systems on patients' adherence to treatment. Patient Prefer Adherence (2012) 1.19
Effects on skills and practice from a web-based skin cancer course for primary care providers. J Am Board Fam Med (2013) 1.19